https://www.zonebourse.com/cours/action/GENPREX-INC-42547899/actualite/Genprex-recoit-la-designation-Fast-Track-de-la-FDA-pour-la-therapie-immunogene-REQORSA-en-associ-44215307/?utm_source=telegram&utm_medium=social&utm_campaign=share